FDA issues warning to controversial Houston cancer doctor
The Food and Drug Administration has issued a strongly worded warning letter to a controversial Houston physician, Stanislaw Burzynski, who was the subject of a USA TODAY investigation last month. Burzynski – hailed as a maverick by his fans but a snake oil salesman by mainstream doctors -- has long claimed to have dramatic success in hard-to-treat cancers, especially brainstem tumors that are usually considered fatal. According to the National Cancer Institute, however, Burzynski has never produced definitive proof that his drugs save lives by publishing a randomized, controlled trial in a peer-reviewed journal.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- How Telehealth Pays Off for Providers, Patients
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application